Nearly three-fourths of the 2.4 million U.S. adults who reported using buprenorphine in 2019 did not misuse the medication in the past 12 months, according to a  released last week in JAMA Network Open. The researchers also found a downward trend of buprenorphine misuse between 2015 and 2019 among those with an opioid use disorder. Individuals who received no drug use treatment and those in rural areas were more likely to misuse the medication.

鈥淭his study provides further evidence to support the need for expanded access to proven treatment approaches, such as buprenorphine therapy, despite the remaining stigma and prejudice that remains for people with addiction and the medications used to treat it,鈥  National Institute on Drug Abuse Director Nora Volkow, M.D. 
 

Related News Articles

Headline
Overdose deaths in the U.S. fell 26.9% last year to 80,391, according to estimates from the Centers for Disease Control and Prevention. The agency reported鈥
Headline
The House Energy and Commerce Committee held a markup April 29 where it advanced the AHA-supported SUPPORT Act (H.R. 2483). The legislation would reauthorize鈥
Headline
The National Institutes of Health April 3 released a study that found an artificial intelligence screening tool was as effective as health care providers in鈥
Headline
The Department of Health and Human Services March 18 announced that it renewed the public health emergency for the nation鈥檚 opioid crisis an additional 90 days鈥
Headline
The Department of Health and Human Services Office of Inspector General Feb. 18 released a report that found about 40% of Medicare enrollees who began opioid鈥
Headline
Today the Drug Enforcement Administration and Department of Health and Human Services announced that the effective date for the final rule regarding鈥